Dr. Minmin Yen (Mimi) researched the use of phages as an intervention for cholera during her thesis work in the Camilli Lab at Tufts University, resulting in publications in Nature Communications and eLife. As a biological engineering undergraduate at MIT, she trained with Professors David Schauer and Darrell Irvine and researched oral vaccine delivery. Passionate about developing innovative solutions for infectious diseases, Mimi was awarded the Howard Hughes Medical Institute MERGE-ID fellowship, which focused on translating bench science to clinical applications, for her graduate education. During her thesis research, Mimi traveled to Haiti to study the cholera epidemic, where she witnessed the need for innovative healthcare solutions. She also served as the U.S. representative in the Young Leaders Circle for three years as a part of American Society of Microbiology’s initiative to address the needs of international early-stage scientists. Mimi recently received her Master’s in Public Health at Boston University, with a focus in global health and program management.

Dr. Andrew Camilli (Andy) is a Professor in the Department of Molecular Biology & Microbiology at Tufts University. He trained with two leaders in the field of microbiology: Daniel Portnoy at the UPenn School of Medicine and John Mekalanos at Harvard Medical School. With over 20 years of experience, Andy is an internationally recognized leader in the field of microbiology, whose research centers on two major human pathogens, Vibrio cholerae, the causative agent of cholera, and Streptococcus pneumoniae, a major cause of bacterial pneumonia. He has published 132 peer-reviewed papers and 25 reviews and book chapters, including papers in Nature, Cell, Science, eLife, PNAS, and many top journals in the field of microbiology such as Nature Microbiology and PLoS Pathogens. He has six US patents awarded and two applications filed. He has been continuously funded by NIH since 1996 and was a funded HHMI investigator from 2005-2018. He has received several prestigious honors and awards, including a Pew Scholar Award, Eli Lilly and Company Research Award, and Election to the American Academy of Microbiology. He currently is a standing member of the Microbiology and Infectious Diseases Review Committee at NIH/NIAID, and instructor of the Advanced Bacterial Genetics course at Cold Spring Harbor Laboratory.

Dr. Gabrielle Grandchamp is an experienced microbiologist with a passion for improving global health. Prior to joining the PhagePro team, Gabrielle researched microbial community dynamics as a graduate student in Dr. Elizabeth Shank’s Laboratory at the University of North Carolina at Chapel Hill. Her thesis work examined the effects of bacterial interactions on cell physiology, specifically sporulation, antibiotic production, and biofilm formation, resulting in multiple publications. As a biochemistry undergraduate, Gabrielle always held an interest in antibiotics and fighting antibiotic resistance and pursued independent research in Dr. Jason Sello’s Laboratory at Brown University researching antibiotic production in Streptomyces. Following her undergraduate degree, Gabrielle continued to research antibiotics and was awarded the Horizon Award for her thesis work pursuing novel antibiotic discovery. While at UNC, Chapel Hill Gabrielle took on multiple leadership roles demonstrating her commitment to sharing science with the community and improving career development for early-stage scientists. At PhagePro, Gabrielle plans to use her diverse skill set to combat the spread of antibiotic resistance and improve human health in vulnerable communities worldwide.